PREEMPTION AND PERSONAL JURISDICTION IN A POST-SCALIA WORLD. PRESENTED BY DAVID HOLMAN and JOHN K. CRISHAM OCTOBER 5, 2016

Size: px
Start display at page:

Download "PREEMPTION AND PERSONAL JURISDICTION IN A POST-SCALIA WORLD. PRESENTED BY DAVID HOLMAN and JOHN K. CRISHAM OCTOBER 5, 2016"

Transcription

1 PREEMPTION AND PERSONAL JURISDICTION IN A POST-SCALIA WORLD PRESENTED BY DAVID HOLMAN and JOHN K. CRISHAM OCTOBER 5, 2016

2 INTRO: JUSTICE SCALIA S SIGNIFICANCE His view did not always win and it often lost but his combination of brilliance, eloquence and good timing... ensured that his ideas, originalism in constitutional law and textualism in statutory interpretation, would set the agenda for a serious judicial conservatism and define the worldview that any living Constitution liberal needed to wrestle with in order to justify his own position. Ross Douthat, New York Times, Feb. 13, 2016

3 DRUG & DEVICE PREEMPTION IN A POST-SCALIA WORLD: From Wyeth to Bartlett and Beyond

4 ROADMAP Significant shift in the scope of pharmaceutical products cases over last decade. Three core topics for today: Discuss Supreme Court s decisions in Riegel, Wyeth, Mensing, and Bartlett, and their aftermath Look at the continued challenges for the industry Finally, consider the effect Justice Scalia s absence might have on the Court s resolution of preemption defenses brought by drug and device manufacturers But first, let s start with some basic principles so we re all on the same page

5 WHAT IS PREEMPTION? Preemption arises when a provision of state law conflicts with a provision of federal law. When that happens, federal law is said to trump, or preempt, the state law. Can be a state statute, a state regulation, or even a state common-law claim. In the drug-and-device context, the most common form is a state-law tort claim.

6 WHY DOES FEDERAL LAW PREEMPT STATE LAW? Because the United States Constitution says so

7 THREE DIFFERENT SPECIES OF PREEMPTION Preemption comes in several distinct, but inter-related forms: Express preemption Field preemption Conflict preemption

8 THREE DIFFERENT SPECIES OF PREEMPTION Express Preemption: when the statutory text says that state law claims are barred. Good Example: Medical Device Amendments

9 THREE DIFFERENT SPECIES OF PREEMPTION, CONT. Field Preemption: When Congress has legislated in such a way that is so comprehensive as to occupy the entire field, leaving no room for conflicting, or even complementary, state regulation. Good Example: Immigration laws.

10 THREE DIFFERENT SPECIES OF PREEMPTION, CONT. Conflict Preemption: when compliance with a state requirement would [A] cause a regulated party to violate federal law or [B] otherwise violate the purpose of federal law Two kinds of conflict preemption: Impossibility preemption Purposes and Objectives preemption

11 IMPOSSIBILITY PREEMPTION Impossibility preemption arises where it is impossible for a private party to comply with both state and federal requirements.

12 PURPOSES-AND-OBJECTIVES PREEMPTION Purposes and objectives, or obstacle, preemption arises where enforcing a particular state law would so impede Congress s goal in pursuing a particular statutory scheme. Good example: Seatbelt laws.

13 WHO DECIDES PREEMPTION QUESTIONS? Any court can be called on to resolve a preemption question whether state or federal, trial or appellate The Supreme Court itself decides preemption questions in any number of areas from environmental law, to employment, to immigration, to arbitration, and, as relevant here, to drug and device law In fact, in just the last decade, the Supreme Court has decided no less than four different cases turning on questions of preemption in the drug and device context

14 Riegel v. Medtronic, 552 U.S. 312 (2008) (Scalia, J.) Plaintiff was implanted with a balloon catheter. His heart became blocked and he had to go into emergency surgery. He later sued Medtronic, which made the device, claiming that it was unsafely designed and labeled. The company argued that the claim was expressly preempted under the MDA because the design and labeling was subjected to rigorous FDA review, and because the state requirements were thus different from what FDA had required.

15 Riegel, cont. The Supreme Court, with Justice Scalia writing, agreed that the claim was preempted. As Justice Scalia wrote, common-law duties impose requirements just like positive law does:

16 STATUS OF PREEMPTION FOR MEDICAL DEVICE MAKERS? In Riegel s wake, the general rule is that state-law tort claims targeting Class III manufacturers are expressly preempted However, several courts have carved out an exception for parallel state-law tort claims This exception comes from how these courts have read the express-preemption provision, and from language in Riegel that referenced, but did not sanction, the theory As we ll see in a bit, plaintiffs have attempted to convince courts to adopt a similar exception in drug cases

17 Wyeth v. Levine, 555 U.S. 555 (2009) Plaintiff developed gangrene after IV Phenergan, resulting in amputation. Manufacturer argued impossibility and P&O preemption Held: Federal law does not preempt FTW claims against brands: CBE permits unilateral labeling changes for brands Absent clear evidence that change wouldn t be approved, not impossible for brand to comply with both federal and state requirements. Four justices, including Justice Scalia, dissented Post-Wyeth: Most courts have rejected brand-name companies attempts at preemption dismissals.

18 PLIVA Inc. v. Mensing, 131 S.Ct (2011) Plaintiff ingested generic Reglan (called Metoclopramide) and developed tardive dyskinesia Key holdings State-law tort claims against generics preempted because federal law requires generic labeling to be the same as brand labeling Neither CBE nor Dear Doctor letters available without prior FDA approval No liability for failure to take steps Plaintiffs and the Solicitor General argued that a state-law claim paralleling misbranding statute not preempted; Court found preemption regardless.

19 Mensing, cont. Great decision for generics, but the plaintiffs bar remains inventive in trying to find ways around it Several post-mensing theories pressed in last few years: Disguised FTW claims; i.e., DD, fraud, breach of warranties Failure to update labeling Violations of the FDCA Failure to stop selling RLD designation converts ANDA holder into NDA holder Courts are split on these issues, with really only update succeeding

20 Mutual Pharm. Co. v. Bartlett, 133 S. Ct (2013) State-law design-defect claims against generic manufacturers are preempted because: Can t Change Design: Manufacturers can t unilaterally change drug designs under federal law. Otherwise, the altered chemical would be a new drug that would require its own NDA. And it is a one-molecule drug that can t be redesigned. Id. at Can t Change Warnings: Where a design-defect claim depends on the adequacy of the drug s warnings, federal law prohibits generic drug manufacturers from independently changing their drugs labels. Id. at Court rejected CA1 s stop-selling rationale as incompatible with our pre-emption jurisprudence. Id at Presume that an actor is not required to cease acting to avoid liability. Stop-selling theory would require reversal of decades of its preemption case law.

21 WHAT HAPPENED IN BARTLETT S WAKE? Most courts post-bartlett rejected state-law tort claims, including CA3 (Welch), CA4 (Drager), CA5 (Lashley), CA6 (Strayhorn), CA7 (Houston), and CA10 (Schrock). But the plaintiffs bar is trying to plead around Bartlett. Main carve-out at this point is based on Solicitor General s parallel misbranding exception for pure design-defect claims. Plaintiffs bar has focused in on Bartlett fn. 4 as somehow preserving this theory.

22 CURRENT CHALLENGES FOR BRANDS Post-Mensing, plaintiffs are trying to bring claims against brands even where they took generic. ~ 100 cases rejected claim, but three decisions have accepted it: Conte v. Wyeth: held that it is reasonably foreseeable for brands that doctors will look to branded labeling NB: California Supreme Court has arguably vitiated Conte s core rationale. O Neil v. Crane Co., 266 P.3d 987 (2012) (barring strict liability and negligence claims where defendant did not manufacture the product at issue). Other courts have accepted it too: Kellogg v. Wyeth, Inc., 762 F. Supp. 2d 694 (D. Vt. 2010) Wyeth v. Weeks, 159 So. 3d 649 (Ala. 2014)

23 CURRENT CHALLENGES FOR BRANDS PREEMPTION? Brands invoking preemption must have clear evidence the FDA would not have approved label change. What counts as clear evidence? Where Agency rejected CBE change, PAS revision, or RFA -- preempted. Robinson v. McNeil Consumer Healthcare, 615 F.3d 861 (7th Cir. 2010) (label change) Christison v. Biogen Idec Inc., F. Supp. 3d, 2016 WL , slip op. (D. Utah Aug. 5, 2016) (CBE changes) In re Depakote, 87 F. Supp. 3d 916 (S.D. Ill. 2015) (PAS revision and RFA) Rheinfrank v. Abbott Labs., Inc., 119 F. Supp. 3d 749 (S.D. Ohio 2015) (PAS revision and RFA) In re Fosamax Prods. Liab. Litig., 951 F. Supp. 2d 695 (D.N.J. 2013) (PAS revision) Dobbs v. Wyeth, 797 F. Supp. 2d 1264 (W.D. Okla. 2011) (CBE change) (settled on appeal)

24 CURRENT CHALLENGES FOR GENERICS FDA s Notice of Proposed Rulemaking on CBE Rule FDA trying to amend regulation to allow generics to make unilateral changes, to create parity between NDA holders and ANDA holders with respect to submission of CBE labeling supplements. Real Question Is Whether They Can Do It Contrary to FDCA s sameness requirement and longstanding FDA precedent Inconsistent with Hatch-Waxman s purpose and structure (undermines brand-generic balance) Serious practical problems (confusion for medical professionals, increased costs, could hinder the Affordable Care Act) FDA has since effectively abandoned it at least until after the next election.

25 AGENCY DEFERENCE IN A POST-SCALIA AGE Scalia authored the opinion in Auer v. Robbins, which held that an agency s interpretation of its own regulations is controlling unless the interpretation is plainly erroneous or inconsistent with the regulation. However, he recently began advocating for Auer s abandonment: Perez v. Mortgage Bankers Ass n, 135 S. Ct. 1199, 1213 (2015) (Scalia, J., concurring) ( I would therefore restore the balance originally struck by the APA with respect to an agency s interpretation of its own regulations, not by rewriting the Act in order to make up for Auer, but by abandoning Auer and applying the Act as written. ) Decker v. Nw. Envtl. Def. Ctr., 133 S. Ct. 1326, (2013) (Scalia, J., concurring) ( In any case, however great may be the efficiency gains derived from Auer deference, beneficial effect cannot justify a rule that not only has no principled basis but contravenes one of the great rules of separation of powers: He who writes a law must not adjudge its violation. )

26 AGENCY DEFERENCE IN A POST-SCALIA AGE The Supreme Court has invoked Auer deference in its recent drug and device preemption decisions. In Mensing (authored by Justice Thomas), the Court cited Auer as the basis for the Court s reliance on the FDA s argument in its brief that the CBE regulation prohibits generics from unilaterally changing labeling. Other Justices, meanwhile, have also criticized the use of Auer, at least insofar as it has the effect of shutting down personal-injury claims. In his Bartlett dissent, Justice Breyer noted that he normally gives weight to the FDA s views, but could not do so because the FDA set forth its views only in litigation, set forth conflicting views, and did not solicit the opinion of the public.

27 SPECIFIC JURISDICTION: TWO PARTS The most active area of the law Two parts: 1. Minimum contacts with the forum are required; 2. The lawsuit must arise from forum-related contacts.

28 INTRO: WHAT IS JURISDICTION? At the most general level, two aspects: 1. A government s general power to exercise authority over persons and things within its territory; and 2. A court s power to decide a case or dispute. Black s Law (10th ed. 2014).

29 INTRO: GENERAL VS. SPECIFIC JURISDICTION General jurisdiction: where a person or entity makes itself essentially at home in the forum state That forum can hear any lawsuit related to the defendant. I.e., suing the Broncos in Colorado or Hershey in Pennsylvania. Specific jurisdiction: where the lawsuit arises from the person or entity s single or isolated contacts with the forum state.

30 SUPREME COURT S PERSONAL JURISDICTION ROLE A matter of constitutional interpretation Due Process Clause: Under the 14th Amendment, No state shall... deprive any person of life, liberty, or property, without due process of law.

31 PERSONAL JURISDICTION S COMMON LAW ROOTS Concept existed centuries before the 14th Amendment (1868): Traditionally that proposition was embodied in the phrase coram non judice, before a person not a judge meaning, in effect, that the proceeding in question was not a judicial proceeding because lawful judicial authority was not present, and could therefore not yield a judgment. American courts invalidated, or denied recognition to, judgments that violated this common-law principle long before the Fourteenth Amendment was adopted. Burnham v. Superior Ct., 495 U.S. 604, (1990) (Scalia, J.).

32 PERSONAL JURISDICTION S SIGNIFICANCE FOR LIFE SCIENCES INDUSTRY Predictability! Under current case law, it is arguably possible and courts have held that you can be haled into court in a state where you have no offices, no employees, no travel, no direct business contacts, or no direct sales or distributors, simply by selling your product into the stream of commerce, and it is foreseeable that your product might end up in that state.

33 SPECIFIC JURISDICTION: MINIMUM CONTACTS The defendant must purposefully establish minimum contacts in the forum state. Must be based on an act of the defendant, not the act of the consumer who brings the product into the forum state. So if a family buys a vehicle in the New York City area, takes it on a cross-country trip, and gets injured in Oklahoma, does jurisdiction exist?

34 SPECIFIC JURISDICTION: STREAM OF COMMERCE Must the defendant target the forum state specifically, or is a large enough sales volume toward the forum state enough? The stream of commerce theory Many courts have held that a mere awareness or foreseeability that a product ends up in the forum state is enough for personal jurisdiction to exist. If this is the test, it is hard to find a limit on personal jurisdiction, especially if your sales volume is large enough. If you sell enough widgets, the sheer volume makes it arguably foreseeable that your products end up in every single jurisdiction.

35 SPECIFIC JURISDICTION: STREAM OF COMMERCE Defendant: a Taiwanese manufacturer of tire valve assemblies Relevant sales: sells its product in Taiwan to a Japanese company that incorporates the valve assembly into its motorcycle tire tube Lawsuit: the valve assembly is blamed for a motorcycle accident in California

36 SPECIFIC JURISDICTION: STREAM OF COMMERCE Defendant s California contacts: No offices, property or agents in California Didn t solicit business in California Didn t make direct sales into California Didn t control the distribution of its valve assembly into California But because it was aware that some of its valve assemblies would be incorporated into tire tubes sold in California, and it intentionally placed its product into the stream of commerce, the California Supreme Court held that California courts had jurisdiction

37 SPECIFIC JURISDICTION: STREAM OF COMMERCE Upon review by the U.S. Supreme Court, the Court unanimously found that this was not enough; but it did so in three different opinions, none of which enjoyed a majority. Justice Scalia joined the main opinion, which argued that the Due Process Clause requires something more than that the defendant was aware of its product s entry into the forum state. Five justices found no jurisdiction because it would violate traditional notions of fair play and substantive justice. In other words, it isn t fair.

38 State of the law: SPECIFIC JURISDICTION: STREAM OF COMMERCE Until very recently, this was the law: maybe it was enough to sell your product into the stream of commerce, as long as you were arguably aware that your product would likely end up in the forum state.

39 SPECIFIC JURISDICTION: STATE SPECIFIC? A 2011 case offers a glimmer of hope (J. McIntyre Machinery, Ltd. v. Nicastro) A British-made metal shearing machine injured a worker in New Jersey. Defendant had no direct sales to United States customers, but sold to a United States distributor. Some of its officials attended U.S. conventions, but not in New Jersey. Only 4 machines ended up in New Jersey. New Jersey Supreme Court: this was enough, based on the old stream of commerce theory

40 SPECIFIC JURISDICTION: STATE SPECIFIC? Another fractured Court: Six justices found no jurisdiction. Six-justice majority was also split: Four justices, including Justice Scalia, advanced a very restrictive view of personal jurisdiction, based on sovereignty: a defendant s action to place itself under that forum state s authority. Not enough to show fairness or a defendant s expectation that its product would end up in the forum state. Without any concrete contacts in New Jersey, personal jurisdiction wasn t present.

41 SPECIFIC JURISDICTION: STATE SPECIFIC? Rest of the majority: tried to split the baby. They argued that jurisdiction was lacking without something more : which they suggested would have been a regular flow of sales into New Jersey, or some state-specific action such as state-specific design, advertising, etc.

42 SPECIFIC JURISDICTION: STATE SPECIFIC? Before Justice Scalia died, a growing majority of the Court was dissatisfied with the state of specific jurisdiction law and its open-ended stream of commerce theory. But they weren t unified enough to do something about it. And lower courts are still divided about what Nicastro means.

43 GENERAL JURISDICTION: CONTINUOUS AND SYSTEMATIC Neglected area of the law until recently, probably because establishing specific jurisdiction through the stream of commerce was so easy. Until 2011, the test here was whether a corporation s contacts with the forum state were continuous and systematic. Hard to know where that line is in the closer cases.

44 GENERAL JURISDICTION: ESSENTIALLY AT HOME The Supreme Court unanimously decided that general jurisdiction existed only where the defendant was essentially at home in the forum state. For a corporation, the typical forum for general jurisdiction is its domicile : where it is incorporated or headquartered. Thus, where Goodyear s foreign subsidiaries were sued in North Carolina for a Paris bus accident involving two North Carolina boys, and the tires in question were manufactured in foreign countries by the foreign subsidiaries, no general jurisdiction.

45 Not a bright line rule GENERAL JURISDICTION: ESSENTIALLY AT HOME But a higher bar than continuous and systematic. Difficult to apply essentially at home for large, multinational corporations with various subsidiaries with different roles.

46 GENERAL JURISDICTION: ESSENTIALLY AT HOME Essentially at home clarified in 2014 Daimler AG, the parent company of Mercedes- Benz USA, was sued in California for the actions of its Argentinian subsidiary in the 1983 so-called Dirty War in Argentina. MBUSA is incorporated in Delaware and headquartered in New Jersey, but distributed vehicles to independent California dealerships, and has some corporate facilities in California.

47 GENERAL JURISDICTION: ESSENTIALLY AT HOME The Ninth Circuit found general jurisdiction over Daimler AG because its agent, MBUSA, was subject to general jurisdiction in California. The Supreme Court reversed because Daimler AG itself was not essentially at home in California. The Court clarified that a corporation may be at home in a forum other than its state of incorporation or headquarters only in an exceptional case. Boeing example: headquartered in Illinois, incorporated in Delaware, but with massive operations in Washington State.

48 GENERAL JURISDICTION: CONSENSUS FOR NOW The last two decisions reigning in general jurisdiction were unanimous, but that will probably not continue as the Court explores the exceptional case.

49 GENERAL JURISDICTION: CONSENSUS FOR NOW Further, if both forms of jurisdiction are restricted, then you can bet that the side of the Court that favors the stream of commerce theory will resist additional restrictions on general jurisdiction. Or proponents of universal jurisdiction may push for an even broader stream of commerce theory. See, e.g., Bristol-Myers Squibb v. Superior Ct. (Cal. Aug. 29, 2016): disregarded the second element of specific jurisdiction so suit need not arise from California contacts.

50 GENERAL JURISDICTION: ESSENTIALLY AT HOME EXCEPTIONS? May be ripe for new examination soon. For example, the Tenth Circuit recently held that Daimler didn t change the law of general jurisdiction, and suggested that general jurisdiction is not restricted to the states of incorporation and headquarters. (American Fidelity Assurance v. BNYM (SCOTUS denied cert. petition on Monday))

51 PERSONAL JURISDICTION: AFTER SCALIA Clinton/Merrick Garland Judge Garland did not decide many personal jurisdiction cases, and he decided none since the major decisions of the last several years.

52 PERSONAL JURISDICTION: AFTER SCALIA Trump has taken the unusual step of releasing lists of potential nominees latest two weeks ago Most don t have any significant Supreme Court decisions in the last 5 years None has addressed stream of commerce issue

53 PRACTICAL CONSEQUENCES IN YOUR LITIGATION Both defenses must be pleaded in your answers. Make your record Preservation: a motion to dismiss should be enough in many jurisdictions, as should jury instructions and a motion for directed verdict. Adopt consistent positions across various lawsuits.

54 PREEMPTION AND PERSONAL JURISDICTION IN A POST-SCALIA WORLD OCTOBER 5, 2016 David C. Holman david.holman@dglaw.com (303) John K. Crisham crishamj@gtlaw.com (303)

Product Liability Update

Product Liability Update Product Liability Update In This Issue: July 2011 State Law Rule Mandating Classwide Arbitration of Consumer Claims Stands as Obstacle to Purposes of Federal Arbitration Act and Is Therefore Preempted

More information

Supreme Court Bars State Common Law Claims Challenging Medical Devices with FDA Pre-Market Approval

Supreme Court Bars State Common Law Claims Challenging Medical Devices with FDA Pre-Market Approval report from washi ngton Supreme Court Bars State Common Law Claims Challenging Medical Devices with FDA Pre-Market Approval March 6, 2008 To view THE SUPREME COURT S DECISION IN riegel V. medtronic, Inc.

More information

Will High Court Provide Clarity On 'Clear Evidence'?

Will High Court Provide Clarity On 'Clear Evidence'? Portfolio Media. Inc. 111 West 19 th Street, 5th Floor New York, NY 10011 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Will High Court Provide Clarity On 'Clear

More information

Product Safety & Liability Reporter

Product Safety & Liability Reporter Product Safety & Liability Reporter Reproduced with permission from Product Safety & Liability Reporter, 30 PSLR 840, 08/01/2011. Copyright 2011 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com

More information

Bender's Health Care Law Monthly September 1, 2011

Bender's Health Care Law Monthly September 1, 2011 Bender's Health Care Law Monthly September 1, 2011 SECTION: Vol. 2011; No. 9 Federal Pre-Emption Under The Food, Drug & Cosmetic Act From Medtronic, Inc. V. Lohr; Pliva, Inc. V. Mensing By Frederick R.

More information

Top 10 Food And Drug Product Law Developments For By Anand Agneshwar and Paige Sharpe Arnold & Porter LLP

Top 10 Food And Drug Product Law Developments For By Anand Agneshwar and Paige Sharpe Arnold & Porter LLP Published by Appellate Law360, California Law 360, Food & Beverage Law360, Life Sciences Law360, New Jersey Law360, New York Law360, Product Liability Law360, and Public Policy Law360 on January 8, 2016.

More information

Preemption in Nonprescription Drug Cases

Preemption in Nonprescription Drug Cases drug and medical device Over the Counter and Under the Radar By James F. Rogers, Julie A. Flaming and Jane T. Davis Preemption in Nonprescription Drug Cases Although it must be considered on a case-by-case

More information

on significant health issues pertaining to their products, and of encouraging the

on significant health issues pertaining to their products, and of encouraging the Number 836 March 17, 2009 Client Alert Latham & Watkins Wyeth v. Levine and the Contours of Conflict Preemption Under the Federal Food, Drug, and Cosmetic Act The decision in Wyeth reinforces the importance

More information

High Court Clarifies Tort Law But Skirts Broad Claims

High Court Clarifies Tort Law But Skirts Broad Claims Portfolio Media, Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com High Court Clarifies Tort Law But Skirts Broad Claims

More information

DEFENDING OTHER PARTIES IN THE CHAIN OF DISTRIBUTION

DEFENDING OTHER PARTIES IN THE CHAIN OF DISTRIBUTION DEFENDING OTHER PARTIES IN THE CHAIN OF DISTRIBUTION Publication DEFENDING OTHER PARTIES IN THE CHAIN OF DISTRIBUTION July 16, 2009 On March 4, 2009, the United States Supreme Court issued its much anticipated

More information

New Federal Initiatives Project. Executive Order on Preemption

New Federal Initiatives Project. Executive Order on Preemption New Federal Initiatives Project Executive Order on Preemption By Jack Park* September 4, 2009 The Federalist Society for Law and Public Policy Studies www.fed-soc.org Executive Order on Preemption On May

More information

No IN THE UNITED STATES COURT OF APPEALS FOR THE TENTH CIRCUIT

No IN THE UNITED STATES COURT OF APPEALS FOR THE TENTH CIRCUIT Appellate Case: 16-4050 Document: 01019691148 Date Filed: 09/19/2016 Page: 1 No. 16-4050 IN THE UNITED STATES COURT OF APPEALS FOR THE TENTH CIRCUIT ALEXANDER CERVENY, VICTORIA CERVENY, AND CHARLES CERVENY

More information

Preemption Update: The Legal Landscape since Reigel v. Medtronic, Inc., 128 S.Ct. 999 (2008) Wendy Fleishman Lieff Cabraser Heimann & Bernstein, LLP

Preemption Update: The Legal Landscape since Reigel v. Medtronic, Inc., 128 S.Ct. 999 (2008) Wendy Fleishman Lieff Cabraser Heimann & Bernstein, LLP Preemption Update: The Legal Landscape since Reigel v. Medtronic, Inc., 128 S.Ct. 999 (2008) Wendy Fleishman October 5, 2010 1 I. The Medical Device Amendments Act The Medical Device Amendments of 1976

More information

The Supreme Court's Personal Jurisdiction Reckoning

The Supreme Court's Personal Jurisdiction Reckoning Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com The Supreme Court's Personal Jurisdiction Reckoning

More information

- F.3d, 2009 WL , C.A.Fed. (Mass.), April 03, 2009 (NO )

- F.3d, 2009 WL , C.A.Fed. (Mass.), April 03, 2009 (NO ) CITE AS: 1 HASTINGS. SCI. AND TECH. L.J. 269 ARIAD PHARMACEUTICALS, INC. V. ELI LILLY AND COMPANY - F.3d, 2009 WL 877642, C.A.Fed. (Mass.), April 03, 2009 (NO. 2008-1248) I. STATEMENT OF THE FACTS Defendant-Appellant

More information

United States Court of Appeals

United States Court of Appeals United States Court of Appeals FOR THE EIGHTH CIRCUIT No. 08-3850 Gladys Mensing, * * Plaintiff - Appellant, * * v. * * Wyeth, Inc., doing business as Wyeth; * Pliva, Inc.; Teva Pharmaceuticals, * USA,

More information

TADC PRODUCTS LIABILITY NEWSLETTER

TADC PRODUCTS LIABILITY NEWSLETTER TADC PRODUCTS LIABILITY NEWSLETTER Selected Case Summaries Prepared Fall 2013 Editor: I. Summary Joseph S. Pevsner Thompson & Knight LLP Co-Editor: Janelle L. Davis Thompson & Knight LLP Contributing Editor:

More information

) ) ) ) ) ) ) ) ) ) ) )

) ) ) ) ) ) ) ) ) ) ) ) Case :0-cv-00-RCC Document Filed /0/0 Page of 0 0 Richard Stengel, et al., vs. Medtronic, Inc. Plaintiffs, Defendant. IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF ARIZONA No. CV 0--TUC-RCC ORDER

More information

WASHINGTON LEGAL FOUNDATION

WASHINGTON LEGAL FOUNDATION Docket No. FDA-2016-D-2021 COMMENTS of WASHINGTON LEGAL FOUNDATION to the FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH & HUMAN SERVICES Concerning DRAFT GUIDANCE FOR INDUSTRY AND FDA STAFF: DECIDING

More information

Recent Developments in Federal Preemption of Pharmaceutical Drug and Medical Device Product Liability Claims. Bryan G. Scott Elizabeth K.

Recent Developments in Federal Preemption of Pharmaceutical Drug and Medical Device Product Liability Claims. Bryan G. Scott Elizabeth K. Article originally published in 17 THE DEFENDER, Fall 2009, at 22 (publication of the North Carolina Association of Defense Attorneys). Recent Developments in Federal Preemption of Pharmaceutical Drug

More information

SUPREME COURT OF THE UNITED STATES

SUPREME COURT OF THE UNITED STATES Cite as: 564 U. S. (2011) 1 NOTICE: This opinion is subject to formal revision before publication in the preliminary print of the United States Reports. Readers are requested to notify the Reporter of

More information

The Mensing Conundrum: Litigating Generic Drug Injuries in California

The Mensing Conundrum: Litigating Generic Drug Injuries in California The Mensing Conundrum: Litigating Generic Drug Injuries in California It is an elementary maxim of equity jurisprudence that there is no wrong without a remedy. 1 I. Introduction As long as there have

More information

Nos , , IN THE UNITED STATES COURT OF APPEALS FOR THE SIXTH CIRCUIT

Nos , , IN THE UNITED STATES COURT OF APPEALS FOR THE SIXTH CIRCUIT Case: 09-5460 Document: 006110791529 Filed: 11/16/2010 Page: 1 Nos. 09-5509, 09-5460, 09-5466 IN THE UNITED STATES COURT OF APPEALS FOR THE SIXTH CIRCUIT DENNIS MORRIS, Plaintiff-Appellant, v. WYETH INC.,

More information

In the Supreme Court of the United States

In the Supreme Court of the United States No. 13-956 In the Supreme Court of the United States TEVA PHARMACEUTICALS USA, INC., ET AL., PETITIONERS v. SUPERIOR COURT OF CALIFORNIA, ORANGE COUNTY, ET AL. ON PETITION FOR A WRIT OF CERTIORARI TO THE

More information

Allocating Liability for Deficient Warnings on Generic Drugs: A Prescription for Change

Allocating Liability for Deficient Warnings on Generic Drugs: A Prescription for Change Allocating Liability for Deficient Warnings on Generic Drugs: A Prescription for Change ABSTRACT Brand-name pharmaceutical companies create pioneer drugs that cure diseases around the world. However, because

More information

Pliva, Inc. v. Mensing One Year Later

Pliva, Inc. v. Mensing One Year Later Product Liability The State of Failure to Warn Claims Against Generic Drug Manufacturers Pliva, Inc. v. Mensing One Year Later By M. Gabrielle Hils Pliva, Inc. v. Mensing, 131 S. Ct. 2567 (2011), the seminal

More information

BNSF Railway v. Tyrrell

BNSF Railway v. Tyrrell BNSF Railway v. Tyrrell James E. Roberts SENIOR GENERAL ATTORNEY MARCH 14, 2018 Overview Introduction to BNSF Experience in Montana Courts Jurisdictional jurisprudence BNSF v Tyrrell Next Steps BNSF System

More information

Innovator Liability: A Pandora s Box For Pharma Cos.?

Innovator Liability: A Pandora s Box For Pharma Cos.? Portfolio Media. Inc. 111 West 19 th Street, 5th Floor New York, NY 10011 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Innovator Liability: A Pandora s Box For

More information

2013 PA Super 215. Appellants No. 83 EDA 2012

2013 PA Super 215. Appellants No. 83 EDA 2012 2013 PA Super 215 IN RE: REGLAN/METOCLOPRAMIDE LITIGATION, IN THE SUPERIOR COURT OF PENNSYLVANIA APPEAL OF: MORTON GROVE PHARMACEUTICALS INC., AND WOCKHARDT USA, LLC, Appellants No. 83 EDA 2012 Appeal

More information

No UNITED STATES COURT OF APPEALS FOR THE TENTH CIRCUIT. ALEXANDER CERVENY, VICTORIA CERVENY, AND CHARLES CERVENY Plaintiffs/Appellants,

No UNITED STATES COURT OF APPEALS FOR THE TENTH CIRCUIT. ALEXANDER CERVENY, VICTORIA CERVENY, AND CHARLES CERVENY Plaintiffs/Appellants, Appellate Case: 16-4050 Document: 01019655086 Date Filed: 07/11/2016 Page: 1 No. 16-4050 UNITED STATES COURT OF APPEALS FOR THE TENTH CIRCUIT ALEXANDER CERVENY, VICTORIA CERVENY, AND CHARLES CERVENY Plaintiffs/Appellants,

More information

2013 PA Super 216 DISSENTING OPINION BY PLATT, J.: FILED JULY 29, Wyeth appeals from the order overruling its preliminary objections to

2013 PA Super 216 DISSENTING OPINION BY PLATT, J.: FILED JULY 29, Wyeth appeals from the order overruling its preliminary objections to 2013 PA Super 216 IN RE: REGLAN LITIGATION IN THE SUPERIOR COURT OF PENNSYLVANIA APPEAL OF: WYETH LLC, WYETH PHARMACEUTICALS, INC. AND WYETH HOLDINGS CORPORATION (COLLECTIVELY WYETH ) No. 84 EDA 2012 Appeal

More information

The Reverse Read and Heed Causation Presumption: A Presumption That Should Be Given Little Heed

The Reverse Read and Heed Causation Presumption: A Presumption That Should Be Given Little Heed b y J o h n Q. L e w i s, P e a r s o n N. B o w n a s, a n d M a t t h e w P. S i l v e r s t e n The Reverse Read and Heed Causation Presumption: A Presumption That Should Be Given Little Heed Failure-to-warn

More information

NO IN THE SUPREME COURT OF THE UNITE STATES. October Term, 2017 ALICE IVERS. Petitioner, WESTERLY PHARMACEUTICAL, INC. Respondent.

NO IN THE SUPREME COURT OF THE UNITE STATES. October Term, 2017 ALICE IVERS. Petitioner, WESTERLY PHARMACEUTICAL, INC. Respondent. NO. 17-230 IN THE SUPREME COURT OF THE UNITE STATES October Term, 2017 ALICE IVERS Petitioner, v. WESTERLY PHARMACEUTICAL, INC. Respondent. On Writ of Certiorari to the Twelfth Circuit Court of Appeals

More information

The Supreme Court Takes on Personal Jurisdiction: What the Court s Recent Opinions Tell Us About the Future of Personal Jurisdiction

The Supreme Court Takes on Personal Jurisdiction: What the Court s Recent Opinions Tell Us About the Future of Personal Jurisdiction The IDC Monograph Gregory W. Odom Hepler Broom, LLC, Edwardsville James L. Craney Craney Law Group, LLC, Edwardsville The Supreme Court Takes on Personal Jurisdiction: What the Court s Recent Opinions

More information

Expansion Of Personal Jurisdiction Over Foreign Suppliers

Expansion Of Personal Jurisdiction Over Foreign Suppliers Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Expansion Of Personal Jurisdiction Over Foreign Suppliers

More information

IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT Case: 14-40183 Document: 00512886600 Page: 1 Date Filed: 12/31/2014 IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT RICARDO A. RODRIGUEZ, Plaintiff - Appellant Summary Calendar United States

More information

Dobbs V. Wyeth: Are We There Yet, And At What Cost?

Dobbs V. Wyeth: Are We There Yet, And At What Cost? Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Dobbs V. Wyeth: Are We There Yet, And At What Cost?

More information

Case: Document: Page: 1 Date Filed: 09/14/2017

Case: Document: Page: 1 Date Filed: 09/14/2017 Case: 16-3785 Document: 003112726677 Page: 1 Date Filed: 09/14/2017 U.S. Department of Justice Civil Division, Appellate Staff 950 Pennsylvania Ave. NW, Rm. 7259 Washington, DC 20530 Tel: (202) 616-5372

More information

~ln $~e OFR.C.E OF_THE CLERK t reme ourt i mte tate PETITION FOR WRIT OF CERTIORARI

~ln $~e OFR.C.E OF_THE CLERK t reme ourt i mte tate PETITION FOR WRIT OF CERTIORARI Supreme Court, U.S. FILED No. 09- --09-98 ~ln $~e OFR.C.E OF_THE CLERK t reme ourt i mte tate PLIVA, INC.; TEVA PHARMACEUTICALS USA, INC.; UDL LABORATORIES, INC., Petitioners, V. GLADYS MENSING, Respondent.

More information

No IN THE ~upreme q~ourt of tl)e ~nit l~ ~tate~ PLIVA, INC.; TEVA PHARMACEUTICALS USA, INC.; UDL LABORATORIES, INC.

No IN THE ~upreme q~ourt of tl)e ~nit l~ ~tate~ PLIVA, INC.; TEVA PHARMACEUTICALS USA, INC.; UDL LABORATORIES, INC. Supreme CourL U.S~ ~I..ED APR 2 1 2010 No. 09-993 OFFICE OF "rile CLERK...j IN THE ~upreme q~ourt of tl)e ~nit l~ ~tate~ PLIVA, INC.; TEVA PHARMACEUTICALS USA, INC.; UDL LABORATORIES, INC., Vo Petitioners,

More information

No SUPREME COURT OF ALABAMA. WYETH, INC., et al., Defendants-Appellants, v. DANNY WEEKS AND VICKI WEEKS,

No SUPREME COURT OF ALABAMA. WYETH, INC., et al., Defendants-Appellants, v. DANNY WEEKS AND VICKI WEEKS, E-Filed 08/01/2013 @ 04:10:16 PM Honorable Julia Jordan Weller ClerkOf The Cnnrf _ No. 1101397 SUPREME COURT OF ALABAMA WYETH, INC., et al., Defendants-Appellants, v. DANNY WEEKS AND VICKI WEEKS, Plaintiffs-Appellees.

More information

No IN THE upreme ourt of toe niteb tate ACTAVIS ELIZABETH, INC., GLADYS MENSING,

No IN THE upreme ourt of toe niteb tate ACTAVIS ELIZABETH, INC., GLADYS MENSING, Supreme CourL U.S. FILED APR 2 1 2010 No. 09-1039 OFFICE OF "rile CLERK IN THE upreme ourt of toe niteb tate ACTAVIS ELIZABETH, INC., Petitioner, V. GLADYS MENSING, Respondent. On Petition for a Writ of

More information

IN THE UNITED STATES COURT OF APPEALS FOR THE ELEVENTH CIRCUIT. No LISA GOODLIN, Appellant, MEDTRONIC, INC., Appellee.

IN THE UNITED STATES COURT OF APPEALS FOR THE ELEVENTH CIRCUIT. No LISA GOODLIN, Appellant, MEDTRONIC, INC., Appellee. IN THE UNITED STATES COURT OF APPEALS FOR THE ELEVENTH CIRCUIT No. 97-5801 LISA GOODLIN, v. Appellant, MEDTRONIC, INC., Appellee. Appeal from the United States District Court for the Southern District

More information

Supreme Court of the United States

Supreme Court of the United States No. IN THE Supreme Court of the United States IN RE REGLAN LITIGATION PLIVA, INC.; BARR PHARMACEUTICALS, LLC; BARR LABORATORIES, INC.; WATSON LABORATORIES, INC.; TEVA PHARMACEUTICALS USA, INC., Petitioners,

More information

Significant Developments in Personal Jurisdiction:

Significant Developments in Personal Jurisdiction: Significant Developments in Personal Jurisdiction: Daimler Creates New Tools for the Defense Corena G. Larimer Tucker Ellis LLP One Market Plaza Steuart Tower, Suite 700 San Francisco, CA 94105 (415) 617-2400

More information

Buckman Extended: Federal Preemption of State Fraud-on-the-FDA Statutes

Buckman Extended: Federal Preemption of State Fraud-on-the-FDA Statutes Seton Hall University erepository @ Seton Hall Law School Student Scholarship Seton Hall Law 5-1-2014 Buckman Extended: Federal Preemption of State Fraud-on-the-FDA Statutes Christine Anne Gaddis Follow

More information

No IN THE Supreme Court of the United States. NOVO NORDISK A/S, Petitioner, v. SUZANNE LUKAS-WERNER and SCOTT WERNER, Respondents.

No IN THE Supreme Court of the United States. NOVO NORDISK A/S, Petitioner, v. SUZANNE LUKAS-WERNER and SCOTT WERNER, Respondents. No. 13-214 IN THE Supreme Court of the United States NOVO NORDISK A/S, Petitioner, v. SUZANNE LUKAS-WERNER and SCOTT WERNER, Respondents. On Petition for a Writ of Certiorari To the Circuit Court of the

More information

Supreme Court of the United States

Supreme Court of the United States NO. 17-230 IN THE Supreme Court of the United States October Term 2017 ALICE IVERS, Petitioner, v. WESTERLY PHARMACEUTICAL, INC. Respondent. On Writ of Certiorari to the United States Court of Appeals

More information

1a Supreme Court of New Jersey IN RE REGLAN LITIGATION. Argued April 11, Decided Aug. 22, 2016.

1a Supreme Court of New Jersey IN RE REGLAN LITIGATION. Argued April 11, Decided Aug. 22, 2016. 1a Supreme Court of New Jersey IN RE REGLAN LITIGATION. Argued April 11, 2016. Decided Aug. 22, 2016. Justice ALBIN delivered the opinion of the Court. In 2004, the brand-name manufacturer of Reglan, known

More information

pìéêéãé=`çìêí=çñ=íüé=råáíéç=pí~íéë=

pìéêéãé=`çìêí=çñ=íüé=råáíéç=pí~íéë= No. 13-1379 IN THE pìéêéãé=`çìêí=çñ=íüé=råáíéç=pí~íéë= ATHENA COSMETICS, INC., v. ALLERGAN, INC., Petitioner, Respondent. On Petition for a Writ of Certiorari to the United States Court of Appeals for

More information

The Federal Preemption Battle Has Just Begun

The Federal Preemption Battle Has Just Begun Portfolio Media, Inc. 648 Broadway, Suite 200 New York, NY 10012 www.law360.com Phone: +1 212 537 6331 Fax: +1 212 537 6371 customerservice@portfoliomedia.com The Federal Preemption Battle Has Just Begun

More information

DRUG, DEVICE AND BIOTECHNOLOGY

DRUG, DEVICE AND BIOTECHNOLOGY = I suggest the following simple ten ways to avoid malpractice in litigation: DRUG, DEVICE AND BIOTECHNOLOGY August 2013 IN THIS ISSUE This month Brigid Carpenter and Ceejaye Peters review two recent decisions,

More information

Supreme Court of the United States

Supreme Court of the United States No. 15-449 IN THE Supreme Court of the United States JOHNSON & JOHNSON and MCNEIL-PPC, INC., Petitioners, v. LISA RECKIS and RICHARD RECKIS, Respondents. On Petition for a Writ of Certiorari to the Supreme

More information

SUPREME COURT OF THE UNITED STATES

SUPREME COURT OF THE UNITED STATES Cite as: 564 U. S. (2011) 1 NOTICE: This opinion is subject to formal revision before publication in the preliminary print of the United States Reports. Readers are requested to notify the Reporter of

More information

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF LOUISIANA VERSUS NO: TEVA PHARMACEUTICALS USA, INC. ET AL.

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF LOUISIANA VERSUS NO: TEVA PHARMACEUTICALS USA, INC. ET AL. DAVIS UNITED STATES DISTRICT COURT EASTERN DISTRICT OF LOUISIANA CIVIL ACTION VERSUS NO: 13-6365 TEVA PHARMACEUTICALS USA, INC. ET AL. SECTION: "J" (4) ORDER AND REASONS Before the Court is a Motion for

More information

And the Verdict Is...: Recent Trends in Drug and Device Litigation. Presented by: James Beck Steven Boranian Stephen McConnell

And the Verdict Is...: Recent Trends in Drug and Device Litigation. Presented by: James Beck Steven Boranian Stephen McConnell And the Verdict Is...: Recent Trends in Drug and Device Litigation Presented by: James Beck Steven Boranian Stephen McConnell Agenda Personal jurisdiction Preemption Innovator liability Duty to report

More information

NEXT DECADE TO-DO: Enforce Preemption for Class II Devices with Special Controls. Luther T. Munford and Erin P. Lane

NEXT DECADE TO-DO: Enforce Preemption for Class II Devices with Special Controls. Luther T. Munford and Erin P. Lane NEXT DECADE TO-DO: Enforce Preemption for Class II Devices with Special Controls Luther T. Munford and Erin P. Lane 32 The common assumption is that FDA premarket approval of a Class III device is a necessary

More information

BY SHEILA A. SUNDVALL, CHRISTOPHER F. ALLEN, & SUSAN E. JACOBY. I. Introduction. Background

BY SHEILA A. SUNDVALL, CHRISTOPHER F. ALLEN, & SUSAN E. JACOBY. I. Introduction. Background Russell v. SNFA: Illinois Supreme Court Adopts Expansive Interpretation of Personal Jurisdiction Under a Stream of Commerce Theory in the Wake of McIntyre v. Nicastro BY SHEILA A. SUNDVALL, CHRISTOPHER

More information

Case 2:16-cv Document 1 Filed 12/12/16 Page 1 of 101 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF LOUISIANA

Case 2:16-cv Document 1 Filed 12/12/16 Page 1 of 101 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF LOUISIANA Case 2:16-cv-17144 Document 1 Filed 12/12/16 Page 1 of 101 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF LOUISIANA IN RE: TAXOTERE (DOCETAXEL) MDL No. 2740 PRODUCTS LIABILITY LITIGATION

More information

PLIVA v. Mensing and Its Implications

PLIVA v. Mensing and Its Implications Georgetown University Law Center Scholarship @ GEORGETOWN LAW 2011 PLIVA v. Mensing and Its Implications Brian Wolfman Georgetown University Law Center, wolfmanb@law.georgetown.edu Dena Feldman Covington

More information

Segal McCambridge Singer & Mahoney, Ltd Market Street, Suite 2600 Philadelphia, PA (215) Fax: (215) : : : : : : : : : :

Segal McCambridge Singer & Mahoney, Ltd Market Street, Suite 2600 Philadelphia, PA (215) Fax: (215) : : : : : : : : : : Theodore C. Flowers, Esquire tflowers@smsm.com Attorney Identification No. 82218 Segal McCambridge Singer & Mahoney, Ltd. 1818 Market Street, Suite 2600 Philadelphia, PA 19103 (215) 972-8015 Fax (215)

More information

Duking It Out: Key Litigation Developments in 2011

Duking It Out: Key Litigation Developments in 2011 Duking It Out: Key Litigation Developments in 2011 David R. Garfield Lori J. Marco Stephen P. Lucke Heather D. Redmond Steven J. Wells Wells Fargo & Company Deputy General Counsel Minneapolis, Minnesota

More information

REGULATORY COMPLIANCE: GLOBAL EDITION

REGULATORY COMPLIANCE: GLOBAL EDITION REGULATORY COMPLIANCE: GLOBAL EDITION Jennifer E. Dubas Endo Pharmaceuticals Michael C. Zellers Tucker Ellis LLP Pharmaceutical and medical device companies operate globally. Global operations involve

More information

J. Mcintyre Machinery, Ltd. v. Nicastro: The Stream-of- Commerce Theory Of Personal Jurisdiction In A Globalized Economy

J. Mcintyre Machinery, Ltd. v. Nicastro: The Stream-of- Commerce Theory Of Personal Jurisdiction In A Globalized Economy University of Miami Law School Institutional Repository University of Miami Law Review 10-1-2001 J. Mcintyre Machinery, Ltd. v. Nicastro: The Stream-of- Commerce Theory Of Personal Jurisdiction In A Globalized

More information

No UNITED STATES SUPREME COURT ALICE IVERS, Petitioner, WESTERLY PHARMACEUTICAL, INC., Respondent

No UNITED STATES SUPREME COURT ALICE IVERS, Petitioner, WESTERLY PHARMACEUTICAL, INC., Respondent No. 17-230 UNITED STATES SUPREME COURT ALICE IVERS, Petitioner, v. WESTERLY PHARMACEUTICAL, INC., Respondent On Writ of Certiorari to the United States Court of Appeals for the Twelfth Circuit BRIEF OF

More information

IN THE Supreme Court of the United States. ALICE IVERS, Petitioner, v. WESTERLY PHARMACEUTICAL, INC., Respondent. BRIEF FOR PETITIONER

IN THE Supreme Court of the United States. ALICE IVERS, Petitioner, v. WESTERLY PHARMACEUTICAL, INC., Respondent. BRIEF FOR PETITIONER No. 17-230 IN THE Supreme Court of the United States ALICE IVERS, Petitioner, v. WESTERLY PHARMACEUTICAL, INC., Respondent. On Writ of Certiorari to the Twelfth Circuit Court of Appeals BRIEF FOR PETITIONER

More information

In the Supreme Court of the United States

In the Supreme Court of the United States Nos. 09-993, -1039, -1501 In the Supreme Court of the United States PLIVA, INC. ET AL., Petitioners, v. GLADYS MENSING, Respondent. ACTIVIS ELIZABETH, LLC, Petitioner, v. GLADYS MENSING, Respondent. ACTIVIS,

More information

Supreme Court of the United States

Supreme Court of the United States No. 17-230 IN THE Supreme Court of the United States October Term, 2017 Alice IVERS, Petitioner, v. WESTERLY PHARMACEUTICAL, INC., Respondent. On Writ of Certiorari to the Twelfth Circuit Federal Court

More information

SUPREME COURT OF THE UNITED STATES

SUPREME COURT OF THE UNITED STATES (Slip Opinion) OCTOBER TERM, 2010 1 Syllabus NOTE: Where it is feasible, a syllabus (headnote) will be released, as is being done in connection with this case, at the time the opinion is issued. The syllabus

More information

ORDER GRANTING IN PART AND DENYING IN PART MOTION TO TRANSFER OR STAY

ORDER GRANTING IN PART AND DENYING IN PART MOTION TO TRANSFER OR STAY Pfizer Inc. et al v. Sandoz Inc. Doc. 50 Civil Action No. 09-cv-02392-CMA-MJW IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO Judge Christine M. Arguello PFIZER, INC., PFIZER PHARMACEUTICALS,

More information

Indiana Law Review. Volume Number 1 NOTES MATTHEW J. CLARK *

Indiana Law Review. Volume Number 1 NOTES MATTHEW J. CLARK * Indiana Law Review Volume 46 2013 Number 1 NOTES A CRITICAL ANALYSIS OF PLIVA, INC. V. MENSING MATTHEW J. CLARK * INTRODUCTION A wealthy business executive gives her pharmacist a prescription from her

More information

General Jurisdiction After Bauman

General Jurisdiction After Bauman General Jurisdiction After Bauman Donald Earl Childress III* I. INTRODUCTION... 203 II. GUIDANCE FROM BAUMAN... 204 III. QUESTIONS UNANSWERED... 207 IV. CONCLUSION... 208 I. INTRODUCTION On January 14,

More information

Case 1:09-md KAM-SMG Document 159 Filed 01/30/12 Page 1 of 12 PageID #: 1349

Case 1:09-md KAM-SMG Document 159 Filed 01/30/12 Page 1 of 12 PageID #: 1349 Case 1:09-md-02120-KAM-SMG Document 159 Filed 01/30/12 Page 1 of 12 PageID #: 1349 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK ----------------------------------X In re: PAMIDRONATE PRODUCTS

More information

Case 1:06-cv JFK Document 111 Filed 10/27/10 Page 1 of 8

Case 1:06-cv JFK Document 111 Filed 10/27/10 Page 1 of 8 Case 1:06-cv-05513-JFK Document 111 Filed 10/27/10 Page 1 of 8 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK ----------------------------------------X IN RE: : FOSAMAX PRODUCTS LIABILITY LITIGATION

More information

Supreme Court of the United States

Supreme Court of the United States No. 17-230 IN THE Supreme Court of the United States October Term, 2017 Alice IVERS, v. Petitioner, WESTERLY PHARMACEUTICAL, INC., Respondent. On Writ of Certiorari to the United States Court of Appeals

More information

SUPREME COURT OF MISSOURI en banc

SUPREME COURT OF MISSOURI en banc SUPREME COURT OF MISSOURI en banc JODIE NEVILS, APPELLANT, vs. No. SC93134 GROUP HEALTH PLAN, INC., and ACS RECOVERY SERVICES, INC., RESPONDENTS. APPEAL FROM THE CIRCUIT COURT OF ST. LOUIS COUNTY Honorable

More information

In the Supreme Court of the United States

In the Supreme Court of the United States No. 12-1351 In the Supreme Court of the United States MEDTRONIC, INC., PETITIONER v. RICHARD STENGEL AND MARY LOU STENGEL ON PETITION FOR A WRIT OF CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR

More information

Glennen v. Allergan, Inc.

Glennen v. Allergan, Inc. Glennen v. Allergan, Inc. GINGER PIGOTT * AND KEVIN COLE ** WHY IT MADE THE LIST Prescription medical device manufacturers defending personal injury actions have a wide variety of legal defenses not available

More information

Choice of Law and Punitive Damages in New Jersey Mass Tort Litigation

Choice of Law and Punitive Damages in New Jersey Mass Tort Litigation Choice of Law and Punitive Damages in New Jersey Mass Tort Litigation by Kenneth J. Wilbur and Susan M. Sharko There is now an emerging consensus that where the alleged wrongful conduct giving rise to

More information

Top Food and Drug Cases, 2017, & Cases to Watch, Edited by August T. Horvath

Top Food and Drug Cases, 2017, & Cases to Watch, Edited by August T. Horvath Top Food and Drug Cases, 2017, & Cases to Watch, 2018 Edited by August T. Horvath Reprinted with the permission of FDLI. Top Food and Drug Cases, 2017 & Cases to Watch, 2018 Contents Introduction 3 August

More information

Supreme Court of the United States

Supreme Court of the United States No. 17-230 IN THE Supreme Court of the United States Alice IVERS, v. WESTERLY PHARMACEUTICAL, INC., Petitioner, Respondent. On Writ of Certiorari to the Twelfth Circuit Federal Court of Appeals BRIEF FOR

More information

Alexander Hamilton Wins

Alexander Hamilton Wins 03.14.2008 Alexander Hamilton Wins During the debate on the federal Constitution in Philadelphia in the summer of 1787, Alexander Hamilton, the prodigy mentored by George Washington who ultimately wrote

More information

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI EASTERN DIVISION

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI EASTERN DIVISION Case: 4:17-cv-02584-SNLJ Doc. #: 47 Filed: 01/24/18 Page: 1 of 13 PageID #: 1707 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI EASTERN DIVISION NEDRA DYSON, et al. ) ) ) Plaintiffs, ) ) v.

More information

U.S. Supreme Court Update

U.S. Supreme Court Update Hot Topics in the High Court: U.S. Supreme Court Update Presented by: Susan L. Bickley, Blank Rome LLP Cheryl S. Chang, Blank Rome LLP William R. Cruse, Blank Rome LLP Ann B. Laupheimer, Blank Rome LLP

More information

NOTES S. Ct (2009). 6. Id. at See id. at Id. 9. Id. at 1204.

NOTES S. Ct (2009). 6. Id. at See id. at Id. 9. Id. at 1204. NOTES Warning, This Decision Will Increase the Cost of Prescription Drugs: How the Supreme Court s Misapplication of Preemption Doctrine in Wyeth V. Levine Portends Devastating Consequences for Oklahoma

More information

"The Reports of the Death of Federal Multi-State Class Actions Have Been Greatly Exaggerated"

The Reports of the Death of Federal Multi-State Class Actions Have Been Greatly Exaggerated From: HarrisMartin's Mdl Mass Tort & Class Action Monitor Publication Date: December 15, 2017 www.harrismartin.com "The Reports of the Death of Federal Multi-State Class Actions Have Been Greatly Exaggerated"

More information

UNITED STATES DISTRICT COURT DISTRICT OF NEW HAMPSHIRE. v. Civil No. 08-cv-358-JL Opinion No DNH 144 Mutual Pharmaceutical Company, Inc. et al.

UNITED STATES DISTRICT COURT DISTRICT OF NEW HAMPSHIRE. v. Civil No. 08-cv-358-JL Opinion No DNH 144 Mutual Pharmaceutical Company, Inc. et al. UNITED STATES DISTRICT COURT DISTRICT OF NEW HAMPSHIRE Karen L. Bartlett and Gregory S. Bartlett v. Civil No. 08-cv-358-JL Opinion No. 2009 DNH 144 Mutual Pharmaceutical Company, Inc. et al. O R D E R

More information

PREEMPTION AND THE PHYSICIAN PAYMENTS SUNSHINE ACT TOPICS. Overview of Preemption. Recent Developments. Consequences and Strategies

PREEMPTION AND THE PHYSICIAN PAYMENTS SUNSHINE ACT TOPICS. Overview of Preemption. Recent Developments. Consequences and Strategies PREEMPTION AND THE PHYSICIAN PAYMENTS SUNSHINE ACT Robert N. Weiner October 22, 2008 TOPICS Overview of Preemption Recent Developments Consequences and Strategies OVERVIEW OF PREEMPTION SUPREMACY CLAUSE

More information

IN THE SUPREME COURT OF THE UNITED STATES

IN THE SUPREME COURT OF THE UNITED STATES No. 17-230 IN THE SUPREME COURT OF THE UNITED STATES ALICE IVERS, v. WESTERLY PHARMACEUTICAL INC., Petitioner, Respondent. ON WRIT OF CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR THE TWELFTH CIRCUIT

More information

v. Docket No Cncv

v. Docket No Cncv Phillips v. Daly, No. 913-9-14 Cncv (Toor, J., Feb. 27, 2015). [The text of this Vermont trial court opinion is unofficial. It has been reformatted from the original. The accuracy of the text and the accompanying

More information

4/10/2017 1:02 PM COMMENTS WHEN IS IT NECESSARY FOR CORPORATIONS TO BE ESSENTIALLY AT HOME?: AN EXPLORATION OF EXCEPTIONAL CASES INTRODUCTION

4/10/2017 1:02 PM COMMENTS WHEN IS IT NECESSARY FOR CORPORATIONS TO BE ESSENTIALLY AT HOME?: AN EXPLORATION OF EXCEPTIONAL CASES INTRODUCTION COMMENTS WHEN IS IT NECESSARY FOR CORPORATIONS TO BE ESSENTIALLY AT HOME?: AN EXPLORATION OF EXCEPTIONAL CASES INTRODUCTION This comment examines the current state of the law surrounding the exercise of

More information

THE SAFE HARBOR PROVISION OF HATCH-WAXMAN IS THERE A HOLE IN THE SAFETY NET?

THE SAFE HARBOR PROVISION OF HATCH-WAXMAN IS THERE A HOLE IN THE SAFETY NET? THE SAFE HARBOR PROVISION OF HATCH-WAXMAN IS THERE A HOLE IN THE SAFETY NET? The Drug Price Competition and Patent Term Restoration Act of 1984 (also known as the Hatch-Waxman Act) was enacted for the

More information

Supreme Court of the United States

Supreme Court of the United States No. 12-761 IN THE Supreme Court of the United States POM WONDERFUL LLC, v. Petitioner, THE COCA-COLA COMPANY, Respondent. ON PETITION FOR A WRIT OF CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR

More information

3/6/2018. Bristol-Myers Squibb Co. v. Superior Court of California (June 19, 2017)

3/6/2018. Bristol-Myers Squibb Co. v. Superior Court of California (June 19, 2017) Home Alone and the Death of Mass Torts: Recent Developments in General and Specific Jurisdiction Justice Paige Petersen, Utah Supreme Court Judge Diana Hagen, Utah Court of Appeals Moderator: Erik A. Christiansen,

More information

Supreme Court of the United States

Supreme Court of the United States No. 12-1351 IN THE Supreme Court of the United States MEDTRONIC, INC., Petitioner, v. RICHARD STENGEL and MARY LOU STENGEL, Respondents. On Petition for a Writ of Certiorari To the United States Court

More information

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION. v. No. 04 C 8104 MEMORANDUM OPINION

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION. v. No. 04 C 8104 MEMORANDUM OPINION Case 1 :04-cv-08104 Document 54 Filed 05/09/2005 Page 1 of 8n 0' IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION GALE C. ZIKIS, individually and as administrator

More information

A Hard Pill to Swallow: Symptoms and Prognosis of the Drug Manufacturer Preemption Defense in 2018

A Hard Pill to Swallow: Symptoms and Prognosis of the Drug Manufacturer Preemption Defense in 2018 Touro Law Review Volume 34 Number 2 Article 17 2018 A Hard Pill to Swallow: Symptoms and Prognosis of the Drug Manufacturer Preemption Defense in 2018 Brandon Stephens Follow this and additional works

More information

March 28, Re: Supplemental Comments Related to Patent Subject Matter Eligibility. Dear Director Lee:

March 28, Re: Supplemental Comments Related to Patent Subject Matter Eligibility. Dear Director Lee: March 28, 2017 The Honorable Michelle K. Lee Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office P.O. Box 1450 Alexandria, Virginia 22313-1450

More information

Drug Preemption v. Medical Device Preemption: A Study in Contrast

Drug Preemption v. Medical Device Preemption: A Study in Contrast Journal of the Kansas Association for Justice u Product liability Drug Preemption v. Medical Device Preemption: A Study in Contrast By Leslie Overfelt and Patrick A. Hamilton Leslie Overfelt, is a staff

More information

Case 2:18-cv GAM Document 15 Filed 07/23/18 Page 1 of 12 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

Case 2:18-cv GAM Document 15 Filed 07/23/18 Page 1 of 12 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA Case 2:18-cv-01959-GAM Document 15 Filed 07/23/18 Page 1 of 12 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA HELEN McLAUGHLIN : CIVIL ACTION NO. 14-7315 : v. : : NO. 18-1144

More information